Seamus O'Reilly
ORCID: 0000-0002-2887-7336
· 1 paper in corpus
case-report
2026
Background: In triple-negative breast cancer (TNBC), the addition of immunotherapy has significantly improved outcomes. Immune-related adverse events (irAEs) can be accelerated in patients with pre-existing autoimmune (AI) conditions. The …